prof. dr. J.A. (Ton) Lisman

Professor of Experimental Surgery

prof. dr. J.A. (Ton) Lisman
Telephone:
E-mail:
j.a.lisman umcg.nl

Research

  1. 2018
  2. Groeneveld, D. J., Sanders, Y. V., Adelmeijer, J., Mauser-Bunschoten, E. P., van der Bom, J. G., Cnossen, M. H., ... Leebeek, F. W. G. (2018). Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study. Thrombosis and Haemostasis, 118(1), 152-160. https://doi.org/10.1160/TH17-06-0397
  3. 2017
  4. Joshi, N., Kopec, A. K., Ray, J. L., Cline-Fedewa, H., Groeneveld, D. J., Lisman, T., & Luyendyk, J. P. (2017). Von Willebrand factor deficiency reduces liver fibrosis in mice. Toxicology and Applied Pharmacology, 328, 54-59. https://doi.org/10.1016/j.taap.2017.05.018
  5. Lisman, J. (2017). Hemostatic and Non-hemostatic Functions of Platelets in Patients with Liver Disease. In P. Gresele, N. S. Kleiman, J. A. Lopez, & C. P. Page (Eds.), Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: an Update (pp. 1169-1181). Springer. https://doi.org/10.1007/978-3-319-47462-5
  6. 2016
  7. Potze, W., Siddiqui, M. S., Boyett, S. L., Adelmeijer, J., Daita, K., Sanyal, A. J., & Lisman, T. (2016). Preserved hemostatic status in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 65(5), 980-987. https://doi.org/10.1016/j.jhep.2016.06.001
  8. Stravitz, R. T., Ellerbe, C., Durkalski, V., Reuben, A., Lisman, T., Lee, W. M., & Acute Liver Failure Study Grp (2016). Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure. Clinical Gastroenterology and Hepatology, 14(4), 613-620. https://doi.org/10.1016/j.cgh.2015.09.029
  9. Leebeek, F. W. G., & Lisman, J. (2016). Hemostatic dysfunction related to liver diseases and liver transplantation. In K. Kaushansky, M. A. Lichtman, J. Prchal, & M. M. Levi (Eds.), Williams Hematology, 9E (pp. 2191-2109). McGraw-Hill Education.
  10. 2015

ID: 291513